Small Molecule Control over Biological Processes

Show simple item record

dc.contributor.advisor Christian Melander, Committee Chair en_US
dc.contributor.advisor David Shultz, Committee Member en_US
dc.contributor.advisor Reza Ghiladi, Committee Member en_US
dc.contributor.advisor Jonathan Lindsey, Committee Member en_US
dc.contributor.author Heinecke, Christine Loraine en_US
dc.date.accessioned 2010-08-19T18:15:19Z
dc.date.available 2010-08-19T18:15:19Z
dc.date.issued 2010-04-05 en_US
dc.identifier.other etd-12162009-145739 en_US
dc.identifier.uri http://www.lib.ncsu.edu/resolver/1840.16/6246
dc.description.abstract Myotonic Dystrophy Type 1 (DM1) is a multisystemic neuromuscular disorder characterized by a (CTG)n (n > 50) triplet repeat expansion in the 3’-UTR of the myotonic dystrophy protein kinase gene (DMPK). Transcription produces aberrant poly(CUG) expansions which sequester a family of alternative splicing regulators, the muscleblind proteins (MBNL1-3). In the absence of muscleblind, CUG-binding proteins mediate aberrant splicing leading to the disease pathology. We investigated cyclic peptides for their ability to disrupt a (CUG)54:MBNL1 interaction as a unified approach towards treating DM1. To this end, we performed a phage display selection using a cysteine constrained cyclic heptapeptide library against immobilized (CUG)54, which evolved four highly conserved cyclic peptides. In an effort to develop cellularly irreducible analogs of the cysteine constrained heptapeptides, we performed solid phase peptide synthesis substituting allyl glycine at the N- and C-terminal positions, which were subjected to ring closing metathesis. One of the selected peptides was shown to bind (CUG)54 and disrupt the (CUG)54:MBNL1 interaction characteristic of DM1 to a small extent. Kinamycin D is a potent antitumor antibiotic; however, its biological mode of action is poorly understood. In order to further elucidate the mechanism by which kinamycin D mediates DNA damage, we employed DNA sequencing gel electrophoresis. We have demonstrated that under reducing conditions, acidic media promotes enhanced DNA cleavage. Additionally, our results indicate that kinamycin D is capable of generating reactive oxygen species under acidic pH in the presence of a reducing agent and that DNA cleavage is dependent on trace iron and hydroxyl radicals. Bone biology and architecture are regulated by the interplay between osteoclasts and osteoblasts. Imbalances in this relationship, which favor osteoclastogenic activity are implicated in a variety of skeletal diseases. In an effort to target osteoclasts and inhibit osteoclastogenesis, we have synthesized 1,4-substituted triazole libraries. Qualitative analysis of osteoclast maturation when treated with our compounds indicates some members of our triazole libraries to be the most potent known inhibitors of osteoclastogenesis ever disclosed. Bacterial biofilm infections are implicated as the cause of many persistent and chronic infections due to antimicrobial resistance and virulence factors conferred by their protective extracellular matrices. Bordetella bronchiseptica is a gram-negative bacterial pathogen known to colonize the respiratory tracts of animals forming biofilms that are highly resistant to antimicrobial therapy. We synthesized and screened a library of 1,4-substituted triazoles for modulation of B. bronchiseptica biofilm formation. We identified one small molecule, which displayed agonistic activity towards B. bronchiseptica in multiple nutrient sources. en_US
dc.rights I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dis sertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to NC State University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report. en_US
dc.subject myotonic dystrophy en_US
dc.subject kinamycin D en_US
dc.subject triazoles en_US
dc.subject cyclic peptides en_US
dc.subject osteoclasts en_US
dc.subject diazo en_US
dc.title Small Molecule Control over Biological Processes en_US
dc.degree.name PhD en_US
dc.degree.level dissertation en_US
dc.degree.discipline Chemistry en_US


Files in this item

Files Size Format View
etd.pdf 74.32Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record